Home LiteratureArticle Details
PMID: 1986032 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.

The Journal of clinical endocrinology and metabolism ·Vol. 72 ·No. 1 ·1991-01-00 ·Pages 96-107

Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA

Abstract

To investigate the mechanisms of insulin resistance in obesity and noninsulin-dependent diabetes mellitus (NIDDM), we examined oxidative and nonoxidative pathways of free fatty acid (FFA) and glucose metabolism in 14 lean and 17 obese (with normal oral glucose tolerance) nondiabetic subjects and in 8 lean and 8 obese subjects with NIDDM. FFA and glucose metabolism were measured using the sequential insulin clamp technique in combination with indirect calorimetry and infusion of [3-3H]glucose and [1-14C]palmitate. Obesity was characterized by enlarged fat mass, which correlated positively with the plasma FFA concentration (r = 0.62; P less than 0.01). FFA metabolism was less sensitive to insulin in obese than in lean nondiabetic subjects, but this defect could be overcome by increasing the plasma insulin concentration. NIDDM patients showed normal sensitivity to the inhibitory action of insulin on FFA metabolism; however, maximal suppression by insulin was impaired. The combination of obesity and NIDDM was associated with a further enhancement of reesterification of FFA than observed in either condition alone. In both obesity and NIDDM, the dose-response curve for suppression of hepatic glucose production by insulin was impaired. While obesity was primarily characterized by reduced sensitivity to the stimulatory action of insulin on oxidative and nonoxidative pathways of glucose metabolism, resistance to the effect of insulin on glucose metabolism in NIDDM was characterized by a reduced maximal response. The combination of obesity and NIDDM further impaired the sensitivity of liver glucose output and glucose oxidation to insulin. The hypothesis is advanced that in uncomplicated obesity, increased availability and oxidation of FFA leads, by the FFA/glucose cycle, to the impairment in glucose utilization. In NIDDM, on the other hand, the defect in glucose utilization is primary, and the enhanced rate of FFA oxidation may represent a compensatory phenomenon.

MeSH Terms
Adult Blood Glucose/metabolism Diabetes Mellitus/blood Diabetes Mellitus, Type 2/blood Fatty Acids, Nonesterified/blood Female Glucose Clamp Technique Glucose Tolerance Test Humans Insulin/blood Insulin Resistance Male Middle Aged Obesity/blood
Chemicals
Blood Glucose Fatty Acids, Nonesterified Insulin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Groop L C
Fourth Department of Medicine, Helsinki University Hospital, Finland.
Saloranta C
Shank M
Bonadonna R C
Ferrannini E
DeFronzo R A
Article Info
Journal
The Journal of clinical endocrinology and metabolism
Abbr.
J Clin Endocrinol Metab
ISSN
0021-972X
Published
1991-01-00
Pages
96-107
Language
English
Region
United States
NLM ID
0375362
Subset
IM
Grants
NIADDK NIH HHS · AM-24092 · United States
FIC NIH HHS · F05-TWO-3451 · United States
NCRR NIH HHS · RR-125 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com